期刊书目 › OTORHINOLARYNGOLOGY(耳鼻喉科) › ESCI期刊Case Reports in Otolaryngology 2024/2025影响因子:0.443 (CASE REP OTOLARYNGOL) (2090-6765). (OTORHINOLARYNGOLOGY)(耳鼻喉科

phase-2-enzyme 发表于 2025-3-25 06:41:59

Submitted on: 09 June 2018.
Revised on: 31 August 2018.
Accepted on: 23 September 2018.

___________________Case Reports in Otolaryngology

mighty 发表于 2025-3-25 10:23:28

http://reply.papertrans.cn/1/49/4832/4832-22.png

无关紧要 发表于 2025-3-25 15:41:33

http://reply.papertrans.cn/1/49/4832/4832-23.png

obviate 发表于 2025-3-25 17:44:07

http://reply.papertrans.cn/1/49/4832/4832-24.png

CRUC 发表于 2025-3-25 21:35:56

Submitted on: 17 July 2011.
Revised on: 16 September 2011.
Accepted on: 05 October 2011.

___________________Case Reports in Otolaryngology

Conscientious 发表于 2025-3-26 01:02:57

http://reply.papertrans.cn/1/49/4832/4832-26.png

书法 发表于 2025-3-26 04:41:12

http://reply.papertrans.cn/1/49/4832/4832-27.png

dermatomyositis 发表于 2025-3-26 09:50:34

http://reply.papertrans.cn/1/49/4832/4832-28.png

使纠缠 发表于 2025-3-26 16:06:12

http://reply.papertrans.cn/1/49/4832/4832-29.png

Myocyte 发表于 2025-3-26 20:39:30

http://reply.papertrans.cn/1/49/4832/4832-30.png

查看完整版本: ESCI期刊Case Reports in Otolaryngology 2024/2025影响因子:0.443 (CASE REP OTOLARYNGOL) (2090-6765). (OTORHINOLARYNGOLOGY)(耳鼻喉科